Andrea Paccone

790 total citations · 1 hit paper
57 papers, 556 citations indexed

About

Andrea Paccone is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrea Paccone has authored 57 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 26 papers in Oncology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrea Paccone's work include Chemotherapy-induced cardiotoxicity and mitigation (25 papers), Peptidase Inhibition and Analysis (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Andrea Paccone is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (25 papers), Peptidase Inhibition and Analysis (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Andrea Paccone collaborates with scholars based in Italy, India and Vietnam. Andrea Paccone's co-authors include Nicola Maurea, Maria Laura Canale, Gerardo Botti, Antônio Barbieri, Vincenzo Quagliariello, Michelino De Laurentiis, Mariarosaria Conte, Lucia Altucci, Andreina Carbone and Domenica Rea and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea Paccone

48 papers receiving 552 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

2021 268 citations Vincenzo Quagliariello, Michelino De Laurentiis et al. Cardiovascular Diabetology profile →

Peers

Countries citing papers authored by Andrea Paccone

Since Specialization

Citations

This map shows the geographic impact of Andrea Paccone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Paccone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Paccone more than expected).

Fields of papers citing papers by Andrea Paccone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Paccone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Paccone. The network helps show where Andrea Paccone may publish in the future.

Co-authorship network of co-authors of Andrea Paccone

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Paccone. A scholar is included among the top collaborators of Andrea Paccone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Paccone. Andrea Paccone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy 2025 ·Cancers ·Vincenzo Quagliariello, Massimiliano Berretta, (unknown), (unknown), (unknown), (unknown), (unknown), Maria Laura Canale, Andrea Paccone, Alessandro Inno, (unknown), Stefano Oliva, Christian Cadeddu Dessalvi, (unknown), (unknown), (unknown), Domenico Gabrielli, Nicola Maurea	7
2	Healthcare Management in Cardio-Oncology, Clinical Strategies and Future Perspectives: A Narrative Review 2025 ·Healthcare ·Vincenzo Quagliariello, Massimiliano Berretta, (unknown), (unknown), Andrea Paccone, (unknown), (unknown), (unknown), Domenico Gabrielli, Andrea Camerini, Carmine Riccio, (unknown), Stefano Oliva, Maria Laura Canale, Nicola Maurea	0
3	SOLUBLE GUANYLATE CYCLASE ACTIVATOR VERICIGUAT PREVENTS ANTHRACYCLINE–MEDIATED CARDIOTOXICITY AND SARCOPENIA THROUGH NO–SGC–CGMP–NLRP3 PATHWAY: POTENTIAL APPLICATION IN CANCER PATIENTS 2024 ·European Heart Journal Supplements ·Vincenzo Quagliariello, (unknown), (unknown), Vincenzo Giordano, (unknown), Michele Barbato, Francesco Izzo, (unknown), (unknown), Andrea Paccone, Alessandro Inno, Nicola Maurea	1
4	The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients 2024 ·Cancers ·Vincenzo Quagliariello, Massimiliano Berretta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maria Laura Canale, Andrea Paccone, Alessandro Inno, (unknown), Domenico Gabrielli, Nicola Maurea	10
5	Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVD_DD‐DI phase II study 2024 ·British Journal of Haematology ·Gaetano Corazzelli, Annarosa Cuccaro, Emanuela Morelli, Manuela Arcamone, Annarosaria De Chiara, Andrea Paccone, Antonella Petrillo, (unknown), Corrado Aversa, (unknown), Francesco Volzone, (unknown), Gaetana Capobianco, (unknown), (unknown), Stefania Crisci, Rosaria De Filippi, Antonio Pinto	1
6	Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 2024 ·Frontiers in Cardiovascular Medicine ·Vincenzo Quagliariello, Margherita Passariello, (unknown), Andrea Paccone, Alessandro Inno, (unknown), (unknown), Laura Manna, (unknown), Maria Laura Canale, (unknown), Paolo A. Ascierto, Domenico Gabrielli, Claudia De Lorenzo, Nicola Maurea	7
7	P173 THERAPEUTIC MANAGEMENT OF FLUOROPYRIMIDINE CARDIOTOXICITY: AN ANECDOTAL CASE 2023 ·European Heart Journal Supplements ·Andrea Paccone, (unknown), Chiara Lestuzzi, (unknown), Maria Laura Canale, Fabio Maria Turazza, Giulia Russo, Giuseppina Gallucci, Massimiliano Camilli, Vincenzo Quagliariello, (unknown), Nicola Maurea	0
8	Abstract 15030: Dapagliflozin Reduces Myocardial and Renal NF-kB Expression in Preclinical Models Exposed to Doxorubicin Through Myd-88 and NLRP3 Pathways: An Hystological Study 2023 ·Circulation ·Nicola Maurea, Maria Laura Canale, Irma Bisceglia, (unknown), Andrea Paccone, (unknown), Domenico Gabrielli, Giuseppe Palma, (unknown), Francesca Bruzzese, (unknown), Renato Franco, Vincenzo Quagliariello	1
9	SGLT2i Dapagliflozin decreases NLRP3, IL-1 and PCSK9 expression in preclinical models of short-term doxorubicin cardiotoxicity 2023 ·European Heart Journal ·Nicola Maurea, Maria Laura Canale, (unknown), (unknown), Giuseppe Palma, (unknown), Francesca Bruzzese, Andrea Paccone, (unknown), (unknown), Séréna Grimaldi, Vincenzo Giordano, (unknown), Vincenzo Quagliariello	2
10	C31 NEXT GENERATION MYOCARDITIS 2023 ·European Heart Journal Supplements ·(unknown), Domenico Cartoni, F Andréoli, Chiara Lestuzzi, Andrea Paccone, Giuseppina Gallucci, (unknown), (unknown), (unknown)	0
11	Cardioncogeriatria: position paper ANMCO sulla gestione cardioncologica del paziente anziano 2022 ·Giornale italiano di cardiologia ·Irma Bisceglia, Maria Laura Canale, Massimiliano Camilli, Giuseppina Gallucci, Alice Laudisio, Chiara Lestuzzi, Giulia Russo, Fabio Maria Turazza, (unknown), Andrea Paccone, Nicola Maurea, Iris Parrini, Stefania Angela Di Fusco, Fabiana Lucà, (unknown), Giuseppe Zuccalà, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi	0
12	Abstract 12406: Sglt2i Dapagliflozin Associated to Berberine Reduces Cardiac Cell Apoptosis and Necrosis During Exposure to Her-2 Blocking Agents Through Induction of Pampk and Reduction of Inflammasome, Il-6, Methylglyoxal and Leukotrienes-B4 Levels 2022 ·Circulation ·Nicola Maurea, (unknown), Irma Bisceglia, Maria Laura Canale, (unknown), Andrea Paccone, (unknown), Vincenzo Quagliariello	1
13	DAPAGLIFLOZIN ASSOCIATED TO SACUBITRIL/VALSARTAN (LCZ696) EXERTS ADDITIVE CARDIOPROTECTION IN HUMAN CARDIOMYOCYTES EXPOSED SEQUENTIALLY TO DOXORUBICIN AND TRASTUZUMAB THROUGH MYD88, NLRP3 MEDIATED PATHWAYS AND PRO-INFLAMMATORY CYTOKINES 2022 ·Journal of the American College of Cardiology ·Nicola Maurea, (unknown), (unknown), (unknown), (unknown), (unknown), Andrea Paccone, Irma Bisceglia, Vincenzo Quagliariello	1
14	Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 2022 ·Frontiers in Cardiovascular Medicine ·Vincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, (unknown), Andrea Paccone, Antônio Barbieri, Giuseppe Palma, Antonio Luciano, (unknown), Irma Bisceglia, Maria Laura Canale, Giuseppina Gallucci, Alessandro Inno, Claudia De Lorenzo, Nicola Maurea	40
15	Abstract 12402: Sacubitril-Valsartan Increases Pampk and Reduces Inflammasome, Myddosome, Il-6 and Galectin-3 Levels in Short-Term Doxorubicin-Treated Mice Improving Longitudinal Strain and Ejection Fraction 2022 ·Circulation ·Nicola Maurea, Maria Laura Canale, (unknown), Irma Bisceglia, Andrea Paccone, (unknown), (unknown), Vincenzo Quagliariello	1
16	PCSK9 INHIBITOR EVOLOCUMAB REDUCES CARDIOTOXICITY OF DOXORUBICIN AND TRASTUZUMAB SEQUENTIAL TREATMENT THROUGH MYD88/NF-KB/MTORC1 PATHWAYS 2021 ·Journal of the American College of Cardiology ·Nicola Maurea, Andrea Paccone, (unknown), Gerardo Botti, (unknown), Vincenzo Quagliariello	1
17	The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin breakdown → 2021 ·Cardiovascular Diabetology ·Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antônio Barbieri, M. Monti, Andreina Carbone, Andrea Paccone, Lucia Altucci, Mariarosaria Conte, Maria Laura Canale, Gerardo Botti, Nicola Maurea	268
18	Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression 2021 ·Frontiers in Oncology ·Vincenzo Quagliariello, Massimiliano Berretta, (unknown), (unknown), Andrea Paccone, Ernesta Cavalcanti, R. Taibi, Monica Montopoli, Gerardo Botti, Nicola Maurea	38
19	<p>Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation</p> 2020 ·Journal of Blood Medicine ·Vincenzo Russo, Andrea Paccone, Anna Rago, Valeria Maddaloni, Dario Iafusco, Riccardo Proietti, (unknown), Antonio D’Onofrio, Paolo Golino, Gerardo Nigro	6
20	Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study 2019 ·Cardiology Research ·Renato De Vecchis, Andrea Paccone, Marco Di Maio	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact